Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
Part A — Ch. 1 — Disease Prevention & Health Promotion (5
items)
1)
Reference
Ch. 1 — Disease Prevention & Health Promotion
Question Stem
A 52-year-old man with no significant medical history presents
for routine health maintenance. He asks whether he should
begin colorectal cancer screening. Which approach best aligns
with current screening principles for average-risk adults?
,Options
A. Begin colonoscopy at age 50 and repeat every 10 years only if
symptoms develop.
B. Offer shared decision-making about multiple screening
options starting at age 45 for average-risk adults.
C. Perform fecal immunochemical testing (FIT) annually but only
after age 60.
D. No screening is necessary unless there is a family history of
colorectal cancer.
Correct Answer
B
Rationales
Correct (B): CMDT emphasizes shared decision-making and
offering multiple acceptable screening strategies (colonoscopy,
FIT, CT colonography) beginning at age ~45 for average-risk
adults; choice depends on values, test availability, and
adherence.
Incorrect (A): Beginning at age 50 is outdated for many
guidelines; also colonoscopy frequency and choice should be
individualized.
Incorrect (C): FIT is an acceptable option when done annually,
but it is recommended starting earlier (~45) in average-risk
adults, not delayed to 60.
Incorrect (D): Family history increases risk, but absence of
family history does not eliminate need for routine screening.
,Teaching Point
Begin colorectal cancer screening ~age 45 with shared decision-
making about modality.
Citation (Simplified APA)
Papadakis et al. (2026). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Ch. 1. AccessMedicine
2)
Reference
Ch. 1 — Disease Prevention & Health Promotion
Question Stem
A 28-year-old woman planning pregnancy asks which
preconception intervention most reduces risk of neural tube
defects in the fetus. Which is best to recommend?
Options
A. Daily aspirin 81 mg during the first trimester.
B. Folic acid 400–800 µg daily starting before conception.
C. High-dose vitamin D weekly starting at 20 weeks’ gestation.
D. Zinc supplementation only after positive pregnancy test.
Correct Answer
B
Rationales
Correct (B): CMDT highlights periconception folic acid
supplementation (400–800 µg daily) beginning prior to
, conception as effective prevention for neural tube defects.
Incorrect (A): Low-dose aspirin reduces preeclampsia risk in
high-risk women but does not prevent neural tube defects.
Incorrect (C): Vitamin D is important in pregnancy for bone
health, but high-dose vitamin D is not the primary prevention
for neural tube defects and timing is later.
Incorrect (D): Zinc is not the recommended primary
intervention for neural tube defect prevention.
Teaching Point
Start folic acid before conception to reduce neural tube defect
risk.
Citation (Simplified APA)
Papadakis et al. (2026). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Ch. 1. AccessMedicine
3)
Reference
Ch. 1 — Disease Prevention & Health Promotion
Question Stem
A 65-year-old woman with hypertension asks about influenza
and pneumococcal vaccination. According to preventive care
priorities, which statement is most accurate?
Options
A. Influenza vaccination is optional in older adults with chronic
disease.